Shilpa Gupta Md

Shilpa Gupta on Maintenance Therapy for Bladder Cancer

GU Oncology Now

Shilpa Gupta MD on Later Line Therapy for Metastatic Bladder Cancer

Shilpa Gupta, Untitled, 58th International Art Exhibition, May You Live In Interesting Times,

EV-103: EV with pembrolizumab in cisplatin-ineligible urothelial carcinoma

EV-302 Patient-Reported Outcomes

GU Oncology Now

Genitourinary (GU) ASCO 2022 Highlights - OncBrothers (Rohit and Rahul Gosain) with Dr. Shilpa Gupta

OncBrothers: Practice-Changing Cancer Discussions

Management of BCG Failure in Non-Muscle Invasive Bladder Cancer - Medpage Today

OS of patients with mCRPC with PTEN loss-of-function identified by genomic profiling

Immunotherapy Progress in Bladder Cancer

Targeted Oncology

New promise in treating mBC: combining anti-AR therapy with chemotherapy

Factors impacting response to ICIs in mUC

"I'm not just a doctor for the kid - I'm a doctor for the whole family." - Shilpa Gupta

Riverside Medical Clinic

Dr. Gupta on Challenges of Identifying Biomarkers in Bladder Cancer

Bladder Cancer Treatment Decisions: What’s Right for You?

Patient Empowerment Network

SWOG S1216: ADT and TAK700 in prostate cancer

Dr. Gupta on Challenges With Perioperative Immunotherapy in Bladder Cancers

The U.S. Physician PARADIGM Study

The impact of antibiotic use on ICI treatment in mUC

Current Treatment Approaches for Bladder Cancer

Patient Empowerment Network

Redefining Cisplatin-Eligibility for Muscle-Invasive Bladder Cancer